Use of the IL-6R antagonist tocilizumab in hospitalized COVID-19 patients.
Patel K, Gooley TA, Bailey N, Bailey M, Hegerova L, Batchelder A, Holdread H, Dunleavy V, Downey T, Frisvold J, Megrath S, Pagarigan K, Szeto J, Rueda J, Islam A, Maree C, Nyatsatsang S, Bork SE, Lipke A, O'Mahony DS, Wagner T, Pulido J, Mignone J, Youssef S, Hartman M, Goldman JD, Pagel JM.
Patel K, et al. Among authors: bork se.
J Intern Med. 2021 Mar;289(3):430-433. doi: 10.1111/joim.13163. Epub 2020 Oct 20.
J Intern Med. 2021.
PMID: 32745348
Free PMC article.
No abstract available.